Patents by Inventor Nishant Vaikath

Nishant Vaikath has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENGINEERED PICOBODY TO ALPHA SYNUCLEIN
    Publication number: 20240052022
    Abstract: Alpha synuclein picobodies, which are N-terminal truncations of alpha synuclein nanobodies are provided. Methods of using alpha synuclein picobodies for diagnosing and treating synucleinopathies are also provided.
    Type: Application
    Filed: August 14, 2023
    Publication date: February 15, 2024
    Inventors: Prasanna R. Kolatkar, Zeyaul Islam, Issam Hmila, Nishant Vaikath, Omar El-Agnaf
  • ANTIBODY COMPOSITIONS TARGETING NON-PHOSPHORYLATED a-SYNUCLEIN AGGREGATES
    Publication number: 20230365665
    Abstract: The present specification provides a monoclonal antibody that specifically binds aggregated, non-phosphorylated ?-synuclein and a hybridoma producing it. Also disclosed are methods of generating antibodies that specifically binds aggregated, non-phosphorylated ?-synuclein and uses thereof. Uses of anti-?-synuclein antibody in detection and diagnostic assays, and for prophylaxis or therapy of ?-synuclein-associated neurodegenerative diseases, are also disclosed.
    Type: Application
    Filed: September 17, 2021
    Publication date: November 16, 2023
    Inventors: Omar El-Agnaf, Nour Khaled Majbour, Nishant Vaikath
  • ANTIBODY COMPOSITIONS TARGETING NON-PHOSPHORYLATED ALPHA-SYNUCLEIN AGGREGATES
    Publication number: 20220089708
    Abstract: The present specification provides a monoclonal antibody that specifically binds aggregated, non-phosphorylated ?-synuclein and a hybridoma producing it. Also disclosed are methods of generating antibodies that specifically binds aggregated, non-phosphorylated ?-synuclein and uses thereof. Uses of anti-?-synuclein antibody in detection and diagnostic assays, and for prophylaxis or therapy of ?-synuclein-associated neurodegenerative diseases, are also disclosed.
    Type: Application
    Filed: October 26, 2021
    Publication date: March 24, 2022
    Inventors: Omar El-Agnaf, Nour Khaled Majbour, Nishant Vaikath